Genetic modification method of target gene in genome
A genetic transformation and genome technology, applied in the direction of microorganism-based methods, biochemical equipment and methods, and the use of vectors to introduce foreign genetic materials, can solve the problem of low probability of success
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0185] Embodiment 1, construction Red recombinase+I-SceI endonuclease bifunctional auxiliary (helper) plasmid
[0186] 1. Construction of plasmids expressing I-SceI with rha promoter and λRED recombinase with arabinose promoter
[0187] The specific operation steps are: rhaRas (NcoI) and rhaov primers amplify the genome of Escherichia coli w3110 to obtain Fragment B (about 2 kb) containing a rhamnose promoter (rhaB promoter). I-SceIup and I-SceIdn (NcoI) amplify the pUC19RP12 plasmid (Nucl. Acids Res. (1999) 27 (22): 4409-4415) to obtain fragment C (about 0.7kb) containing the I-SceI endonuclease gene .
[0188] rhaRas (NcoI): ACCATGGGGCATGGCGAATTAATCT (SEQ ID NO: 1);
[0189] I-SceIdn (NcoI): TCCATGGTTATTATTTCAGGAAA (SEQ ID NO: 2);
[0190] I-SceIup: ATGCATCAAAAAAACC (SEQ ID NO: 3);
[0191] Rhaov: GGTTCATTACCTGGTTTTTTTTGATGCATAATGTGATCCTGCTGAAT (SEQ ID NO: 4).
[0192] The two fragments B and C were linked together by Overlap PCR and cloned into pMD18simple-T vector. T...
Embodiment 2
[0215] Embodiment 2, construction has the cloning vector of I-SceI restriction site
[0216]First, a 1.5 kb fragment containing the kanMX gene was excised from pUG6 (from EUROSCARF; see Güldener, U. et al.; 1996; Nucleic Acids Research24, 2519-2524) with NotI, and connected into pBluecript II KS(-) (Nucleic Acids Res17 :9494, from the NotI site of Stratagene) to obtain pKS-K.
[0217] The kanMX gene of pKS-K was amplified with primers T3_IsceI and T7_IsceI, digested with BssHII, and reconnected into the BssHII site of pBluecriptIIKS(-). According to the connection direction, two plasmids, pKSKI-1 (the direction of the kanMX gene and the direction of the lacZ fragment of pBluecriptIIKS(-) itself are opposite) and pKSKI-2 (the direction of the kanMX gene and the direction of the lacZ fragment of pBluecriptIIKS(-) itself are the same) were obtained respectively.
[0218] T3_IsceI: AAGCGCGC CCAATTAACCCTCACTAA (SEQ ID NO: 13);
[0219] T7_IsceI: CAGCGCGC TGTAATACGACTCACTA...
Embodiment 3
[0227] Embodiment 3, construction is used for knocking in the template plasmid
[0228] Using pIJ773 and pIJ778 plasmids as templates (PNAS2003100 (4) 1541-1546) respectively, the primer pair Apr-ISceI-F and Apr-ISceI-R were amplified to obtain 1.5 kb containing apramycin (Apr) or spectinomycin ( Spc) resistant fragments. After adding A, it was connected into pMD18-T simple (TAKARA) to obtain pMD-ISceI-apr-ISceI and pMD-ISceI-spc-ISceI plasmids. Such as image 3 and Figure 4 .
[0229] Apr-ISceI-F: 5'TCCCCCGGGGCTAGGGATAACAGGGTAATATTCCGGGGATCCGTCGACC3' (SEQ ID NO: 15);
[0230] Apr-ISceI-R: 5'TCCCCCGGGGCATTACCCTGTTATCCCTAGTGTAGGCTGGAGCTGCTTC3' (SEQ ID NO: 16).
[0231] The pKD3 plasmid (PNAS2003100(4)1541-1546) was digested with XbaI to obtain a 1.0 kb fragment containing chloramphenicol (Cm) resistance. At the same time, the pMD-ISceI-apr-ISceI plasmid was also digested with XbaI, the apramycin resistance fragment was excised, and the vector backbone was retained. Conn...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap